Common use of Responsibilities of Key Pharmacist Clause in Contracts

Responsibilities of Key Pharmacist. The Key Pharmacist must: • Maintain their competency to practice in this speciality by successfully completing all specified training requirements especially the mandatory element of this Agreement (Appendix 1). • Ensure that a NHS GGC Medication Incident Record Form or company specific error reporting form is completed for all medication incidents involving OSTs, whether prescribing, dispensing or administration. • Ensure that any medication incident is promptly reported to Treatment Services, the relevant ADRS or prescriber and CPDT with anonymised details to be disseminated across the network highlighting the remedial action being taken to minimise the risk of reoccurrence. A Significant Event Analysis (SEA) may have to be completed in certain circumstances. • Provide a professional clinical check for all prescriptions prior to dispensing and supply. • Develop and maintain a close working relationship with the prescriber and treatment services. This should include a process to allow information sharing where required. • Ensure a Treatment Agreement is signed by the patient and the pharmacist. It is recommended that a copy is provided to the patient. The patient should fully understand the terms of the Agreement. • Ensure that a Pharmaceutical Care Record (PCR) is created and maintained for each patient, which will include monitoring the response to treatment and medicine information and advice provided. • Ensure that patient medication records are maintained and that the Controlled Drugs register is completed in accordance with current legal requirements. • Ensure that a verifiable audit trail of administered doses is available for those controlled drugs not legally subject to recording requirements. • Provide a verbal/written/electronic summary of progress as per local agreements and in response to patient issues and concerns. • Provide information and advice (and signposting as appropriate) on: o Safe storage and disposal of medicines; o Overdose prevention and Naloxone provision; o Alcohol awareness; o Injecting Equipment Provision and Harm Reduction; o Blood Borne Virus prevention, testing and treatment; o Advice on polypharmacy of prescribed medications; o Smoking cessation (where appropriate); o Healthy eating and exercise; o Sexual health advice and condom provision (where appropriate); o Oral health. • Provide referral and/or signposting to other health services and agencies e.g.

Responsibilities of Key Pharmacist. The Key Pharmacist must: • Maintain their competency to practice in this speciality by successfully completing all specified training requirements especially the mandatory element of this Agreement (Appendix 1). Failure to attend an annual update day in any fiscal year will result in the loss of the final quarterly professional fee paid in March. Failure to attend update training in subsequent years will be monitored and may result in the pharmacy being removed from the Network. • Ensure that all pharmacy staff deployed when the pharmacy is open are fully conversant with the principles of the Service and their designated roles and specific responsibilities in providing the service when a NHS GGC Medication Incident Record Form request is presented (Appendix 2). Display the flowchart (copy in Palliative Care Resource folder) of how to respond within the pharmacy. • Ensure that the support and reference materials provided for information, remain current (Appendix 3), are retained in the pharmacy and are readily available to all pharmacy staff, particularly locum pharmacists and dispensing staff. Contractors may be asked to meet the costs of replacing lost reference materials. Where replacement costs are incurred these will be deducted from payments due to that pharmacy. • Ensure the content of the Resource Folder is always relevant and kept up to date by actioning all updates and amendments issued by the CPDT. • Ensure that the urgency of supply of palliative care drugs is confirmed when the script is presented and that these are provided rapidly and efficiently according to patient, carer and clinical need on an individual basis utilising the collection and delivery of prescriptions facility under the agreed courier protocol if need identified. • Ensure every effort is made to obtain a supply of a drug should a drug on the agreed list not be available for any reason. The Key Pharmacist will take responsibility to source supply from elsewhere e.g. another Network pharmacy or company specific error reporting form a hospital pharmacy department and contact the prescriber for an alternative prescription should these efforts be unsuccessful. One of the specialist palliative care pharmacists can be contacted for advice/help. • Ensure that appropriate advice on the optimal use of these drugs, tailored to the patient’s circumstances is completed provided as routine. • Claim for replacing expired stock by completing the relevant claim contained in the Local Pharmacy Payment Workbook. A supporting invoice must be provided. • Ensure all medication incidents involving OSTspalliative care medicines, whether prescribingprescribing or dispensing, dispensing or administration. • Ensure that any medication incident is are promptly reported to Treatment Services, the relevant ADRS or prescriber and CPDT with Macmillan Lead Pharmacist for Palliative Care in order to complete a Datix report; anonymised details of the incident to be disseminated across the network highlighting the remedial action being taken Network to raise awareness and minimise the risk of reoccurrence. A Significant Event Analysis (SEA) may have to be completed in certain circumstances. • Provide a professional clinical check for all prescriptions prior to dispensing and supply. • Develop and maintain a close working relationship with the prescriber and treatment services. This should include a process to allow information sharing where required. • Ensure a Treatment Agreement is signed by the patient and the pharmacist. It is recommended that a copy is provided Incidents involving controlled drugs must also be reported to the patientAccountable Officer Team. The patient Participants are also encouraged to share independent reports of good practice which should fully understand the terms of the Agreementbe sent to Macmillan Lead Pharmacist for Palliative Care for dissemination. • Ensure that a Pharmaceutical Care Record (PCR) is created and maintained for each patient, which will include monitoring the response to treatment and medicine information and advice provided. • Ensure that patient medication records are maintained and that the Controlled Drugs register is completed in accordance with current legal requirements. • Ensure that a verifiable audit trail of administered doses is available for those controlled drugs not legally subject to recording requirements. • Provide a verbal/written/electronic summary of progress as per local agreements and in response to patient issues and concerns. • Provide information and advice (and signposting as appropriate) on: o Safe storage and disposal of medicines; o Overdose prevention and Naloxone provision; o Alcohol awareness; o Injecting Equipment Provision and Harm Reduction; o Blood Borne Virus prevention, testing and treatment; o Advice on polypharmacy of prescribed medications; o Smoking cessation (where appropriatec); o Healthy eating and exercise; o Sexual health advice and condom provision (where appropriate); o Oral health. • Provide referral and/or signposting to other health services and agencies e.g.